16-88647131-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000101.4(CYBA):āc.173A>Gā(p.Lys58Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000166 in 1,611,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_000101.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.173A>G | p.Lys58Arg | missense_variant | 3/6 | ENST00000261623.8 | NP_000092.2 | |
CYBA | XM_011522905.4 | c.173A>G | p.Lys58Arg | missense_variant | 3/6 | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.173A>G | p.Lys58Arg | missense_variant | 3/6 | 1 | NM_000101.4 | ENSP00000261623.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152066Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000138 AC: 34AN: 246304Hom.: 0 AF XY: 0.000112 AC XY: 15AN XY: 133852
GnomAD4 exome AF: 0.000173 AC: 252AN: 1459184Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 117AN XY: 725916
GnomAD4 genome AF: 0.000105 AC: 16AN: 152066Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74270
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 06, 2018 | - - |
Chronic granulomatous disease Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Feb 26, 2020 | - - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2022 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 58 of the CYBA protein (p.Lys58Arg). This variant is present in population databases (rs200016139, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with CYBA-related conditions. ClinVar contains an entry for this variant (Variation ID: 534659). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at